US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT04613596 Phase 2, Phase 3
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and...
Condition
Advanced Non-Small Cell Lung Cancer
Enrollment
626 pts
Location
United States, Argentina, Australia
Sponsor
Mirati Therapeutics Inc.
View Trial →
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT07604246 N/A
Recruiting
Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Elec...
Condition
Cigarette Smoking-Related Carcinoma
Enrollment
25 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT05535361 N/A
Recruiting
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 S...
Condition
Short Bowel Syndrome
Enrollment
40 pts
Location
United States
Sponsor
Eclipse Regenesis, Inc.
View Trial →
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Tr...
Condition
Gestational Diabetes Mellitus
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT07218380 Phase 3
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary T...
Condition
Carcinoma, Transitional Cell
Enrollment
450 pts
Location
United States, Australia, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT05985161 Phase 2
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Condition
Wilms Tumor
Enrollment
45 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
View Trial →
NCT02418442 N/A
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Condition
Rheumatic Joint Disease
Enrollment
20,000 pts
Location
United States, Canada, Israel
Sponsor
Duke University
View Trial →
NCT02967068 N/A
Recruiting
VCRC Tissue Repository
Condition
Aortitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
View Trial →
NCT06907173 Phase 3
Recruiting
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESE...
Condition
Status Epilepticus
Enrollment
770 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05868668 N/A
Recruiting
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dys...
Condition
Erectile Dysfunction Due to Arterial Insufficiency
Enrollment
186 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT07100080 Phase 2, Phase 3
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy...
Condition
Non-Small Cell Lung Cancer
Enrollment
661 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06552286 N/A
Recruiting
STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade
Condition
Autism Spectrum Disorder
Enrollment
192 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT06251310 Phase 1
Recruiting
SW-682 in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
186 pts
Location
United States
Sponsor
SpringWorks Therapeutics, Inc.
View Trial →
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
View Trial →
NCT07529483 Phase 2
Recruiting
Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysti...
Condition
Pancreatic Cystic Neoplasm
Enrollment
35 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT06223880 Phase 4
Recruiting
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing t...
Condition
Major Depressive Disorder
Enrollment
350 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06738303 Phase 2
Recruiting
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant P...
Condition
Metastatic Prostate Cancer
Enrollment
44 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT07060807 Phase 3
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Condition
Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06689839 N/A
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Condition
Aortic Stenosis Treated With TAVI
Enrollment
500 pts
Location
United States, Australia
Sponsor
EnCompass Technologies, Inc.
View Trial →
NCT03266653 Phase 2
Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Condition
Epstein-Barr Virus Infections
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT03225677 N/A
Recruiting
Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis
Condition
Cirrhosis
Enrollment
20 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
Page 10 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology